Novan Inc. - Company & Market Research Reports

Novan is a late-stage pharmaceutical that develops and commercializes therapies using the its nitric oxide platform. The company's products focus on women's health, as well as central nervous system disorders, including attention deficit hyperactivity disorder (ADHD). The company was founded in 1987 and is based in Miami, Florida. As of August 26, 2009, Noven Pharmaceuticals, Inc. operates as a subsidiary of Hisamitsu Pharmaceutical Co. Inc.